AEGON ASSET MANAGEMENT UK Plc Has $29.67 Million Stock Holdings in Danaher Co. (NYSE:DHR)

AEGON ASSET MANAGEMENT UK Plc cut its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 144,841 shares of the conglomerate's stock after selling 4,923 shares during the period. AEGON ASSET MANAGEMENT UK Plc's holdings in Danaher were worth $29,674,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. LaFleur & Godfrey LLC lifted its stake in Danaher by 1.5% in the fourth quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate's stock valued at $6,853,000 after buying an additional 440 shares in the last quarter. Union Bancaire Privee UBP SA bought a new stake in Danaher in the 4th quarter valued at $74,551,000. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter worth $27,000. Tokio Marine Asset Management Co. Ltd. boosted its stake in Danaher by 0.9% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 18,987 shares of the conglomerate's stock worth $4,358,000 after purchasing an additional 175 shares during the period. Finally, Journey Strategic Wealth LLC increased its holdings in Danaher by 42.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 2,963 shares of the conglomerate's stock worth $680,000 after purchasing an additional 890 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DHR has been the subject of several recent research reports. Royal Bank of Canada reaffirmed an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research report on Monday, April 7th. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Jefferies Financial Group cut their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Finally, Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $263.24.

Insider Transactions at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Danaher Stock Performance

Shares of DHR traded down $1.16 during trading hours on Thursday, hitting $191.92. The company had a trading volume of 3,096,447 shares, compared to its average volume of 4,317,510. The business has a fifty day moving average of $191.68 and a 200-day moving average of $212.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market cap of $137.35 billion, a price-to-earnings ratio of 36.35, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.67%. Danaher's dividend payout ratio (DPR) is 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.